| Filed On | Filing |
|---|---|
| 26 Oct 2026 | 13F-HR |
| 21 Oct 2026 | 10-Q |
| 13 Oct 2026 |
8-K: Results of Operations and Financial Condition
Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. |
| 10 Sep 2026 |
Form 4: Pinto Daniel E, Director
Granted 113.098 Deferred Share Units ($31.3K) |
| 10 Sep 2026 |
Form 4: Woods Eugene A., Director
Granted 135.717 Deferred Share Units ($37.5K) |
| 10 Sep 2026 |
Form 4: Hewson Marillyn A, Director
Granted 180.956 Deferred Share Units ($50K) |
| 04 Sep 2026 |
Form 4: Schmid Timothy, EVP, WW Chair, MedTech
Received 33,597 shares by exercise or conversion ($4.87M) · Sold 33,597 shares ($9.23M) |
| 02 Sep 2026 | 144 |
| 01 Sep 2026 |
Form 3: Cavanaugh Thomas, EVP WW Chair, Innovative Med.
Holds 71 shares of Common Stock |
| 18 Aug 2026 |
Form 4: Taubert Jennifer L, EVP, WWC. Innovative Medicine
Received 15,000 shares by exercise or conversion ($1.74M) · Sold 15,000 shares ($3.95M) |
| 17 Aug 2026 | 144 |
| 14 Aug 2026 |
Form 4: Duato Joaquin, Director
Received 123,291 shares by exercise or conversion ($14.3M) · Sold 123,291 shares ($32.2M) |
| 13 Aug 2026 | 144 |
| 11 Aug 2026 | N-PX |
| 07 Aug 2026 |
Form 4: Duato Joaquin, Director
Sold 48,480 shares ($12.5M) |
| 07 Aug 2026 |
Form 4: Forminard Elizabeth, EVP, Chief Legal Officer
Received 9,344 shares by exercise or conversion ($1.23M) · Sold 15,918 shares ($4.09M) |
| 06 Aug 2026 | 144 |
| 06 Aug 2026 | 13F-HR |
| 05 Aug 2026 | 144 |
| 04 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
Loading...
